SPRING 2013: Volume 29, No. 2
SPRING 2013: Volume 29, No.2 An amazing new technology is restoring some visual ability to people who are blind, a huge step forward for patients and physicians and for Doheny’s mission to restore sight. Featured in this issue: FDA Approves the Argus II Retinal...SPRING 2014: Volume 31, No. 1
SPRING 2014: Volume 31, No.1 Ronald E. Smith, MD, is remembered for his many outstanding qualities. As a clinician and researcher, Dr. Smith specialized in uveitis, cornea, and external disease. Featured in this issue: Blind Championship Golfer Meet the Doheny Team of...SUMMER 2014: Volume 31, No. 2
SUMMER 2014: Volume 31, No. 2 As Doheny embarks on its partnership with UCLA and Stein Eye Institute, new clinics have opened throughout Southern California. Featured in this issue: Doheny Eye Center-UCLA: Orange County, Arcadia, Pasadena Luminaires and Luminaires...FALL 2014: Volume 31, No. 3
FALL 2014: Volume 31, No. 3 Research shows that charitable giving makes us happier. Doheny-trained doctors return the favor. Featured in this issue: Dr. Muzaffar Kirmani Supports Doheny Eye Institute Dr. Richard Villasenor Leads Eye Doctors Treating Patients in Mexico...Brian A. Francis, MD, MS
Brian A. Francis, MD, MS i PubMed Office Locations I Media Brochure Clinical Specialties Glaucoma Cataracts Academic Degrees Bachelor of Science Stanford University Master of Science University of California, Los Angeles Doctor of Medicine Tulane University School...Vikas Chopra, MD
Vikas Chopra, MD i PubMed Office Locations Clinical Specialties Glaucoma Academic Degrees Bachelor of Science Haverford College Doctor of Medicine Pennsylvania State University Residency Ophthalmology Kresge Eye Institute Wayne State University Fellowships Glaucoma...Gad Heilweil, MD
Gad Heilweil, MD i PubMed Office Locations Brochure Clinical Specialties Vitreoretinal surgery Retinal and macular diseases Academic Degrees Doctor of Medicine Technion Institute The Ruth and Bruce Rappaport Faculty of Medicine Residency Ophthalmology Tel Aviv...Hugo Y. Hsu, MD
Hugo Y. Hsu, MD i PubMed Office Locations Brochure Clinical Specialties Corneal infection and inflammation Corneal transplantation Anterior segment reconstruction Cataract surgery Academic Degrees Bachelor of Arts Harvard University Doctor of Medicine University...Kenneth L. Lu, MD
Kenneth L. Lu, MD i PubMed Office Locations Brochure Clinical Specialties Cataract surgery Refractive surgery Academic Degrees Bachelor of Science University of California, Berkeley Doctor of Medicine University of Southern California Residency Ophthalmology...Peter A. Quiros, MD
Peter A. Quiros, MD i PubMed Office Locations Brochure Clinical Specialties Optic nerve disease including optic neuritis and multiple sclerosis Double vision and adult strabismus Eye pain, headache, and idiopathic intracranial hypertension Graves’ disease Orbital...Daniel Rootman, MD, MS
Daniel Rootman, MD, MS i PubMed Office Locations Brochure Clinical Specialties Graves’ disease Orbital surgery Orbital tumors Ptosis Lacrimal disorders Blepharoplasty Blepharospasm Botox Cosmetic dermal fillers Endoscopic eyebrow lift Eyelid surgery Eyelid tumors...SriniVas R. Sadda, MD
SriniVas R. Sadda, MD i PubMed Office Locations I Media Brochure Clinical Specialties Age-related macular degeneration Hereditary retinal degenerations Diabetic retinopathy Venous occlusive disease Telemedicine screening and consultation programs Electronic...John A. Irvine, MD
John A. Irvine, MD i PubMed Office Locations Brochure Clinical Specialties Cornea/external diseases (tumors, infections) Anterior segment surgical consultation Ocular complications of cGVHD Academic Degrees Bachelor of Science Pomona College Master of Science...Alfredo A. Sadun, MD, PhD
Alfredo A. Sadun, MD, PhD i PubMed Office Locations I Media Clinical Specialties Neuro-ophthalmology Optic nerve, optic neuropathies (PION, AION, TON) Leber’s hereditary optic neuropathy Toxic and nutritional optic neuropathies Vision in AIDS and other CNS disorders...Irena Tsui, MD
Irena Tsui, MD i PubMed Office Locations Brochure Clinical Specialties Diabetic laser surgery Macular degeneration therapy Retinal detachment surgery Pediatric retina Retinopathy of prematurity Scleral buckling surgery Vitrectomy Academic Degrees Doctor of...Federico G. Velez, MD
Federico G. Velez, MD i PubMed Office Locations Brochure Clinical Specialties Pediatric ophthalmology Pediatric and adult strabismus, double vision, Ocular motility and alignment disorders, Pediatric cataract and lens disorders Academic Degrees Doctor of Medicine...Welcome to Corner Blog: Insights + Advances
Welcome to The President’s Corner and my first message as the new President and Chief Scientific Officer of the Doheny Eye Institute.
UCLA Health Rises to 3rd in the Nation
UCLA Health’s hospitals in Westwood and Santa Monica have been named to U.S. News and World Report’s 2015-2016 Best Hospitals Honor Roll. UCLA, which previously ranked No. 5 in the country, tied for No. 3 this year.
Doheny Eye Center UCLA Billboards Are Up!
Our billboards are now up!
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis
Doheny Eye Institute is please to announce that Dr. Deming Sun has received an award from the National Institute of Health/National Eye Institute
Summer 2015: Volume 32, No. 1 – Special Edition
Summer 2015: Volume 32, No. 1 – Special Edition Dr. SriniVas Sadda steps in as President and Chief Scientific Officer of the Doheny Eye Institute at a moment of intensified collaborations for Doheny, both globally and closer to home. Featured in this issue: Dr....Happy 50th Anniversary Zhongshan Ophthalmic Center
Gallery of Zhongshan Ophthalmic Center
Carol F. Zimmerman, MD Memorial Lecture
Dr. Sadun will be speaking on “Update on Mitochondrial Neuropathy: From Lebers to Linezolid and What these Diseases Teach us about Basic Biology.”
Now See This: Doheny’s Chinese Partners Unveil Newest Eye Hospital
Last month, I travelled to Guangzhou, China to celebrate the opening of the image reading center at the Zhongshan Ophthalmic Center with our colleagues there.
Behind the Scenes at DEI: Marissa Goldberg Makes It Happen
Doheny Eye Institute is positioned as a world leader in ophthalmologic research and care delivery for at least three key reasons: our excellent infrastructure and environment, hunger for innovation, and our global reach. My colleague, DEI Executive Director Marissa Goldberg, is key to these operations and to the visionary work of this institution in many ways. In short, she makes it happen.
Doheny Society of Scholars & UCLA Ophthalmology Clinical Conference
Description Please join us for a morning of presentations by UCLA Ophthalmology residents and our scholars on a broad spectrum of clinical issues and approaches that are of value to the practicing ophthalmologist followed by the Society of Scholars ceremony and...Luminaires Founders Annual Benefit: Fashion Show Luncheon
Annual UCLA Stein / Doheny Comprehensive Ophthalmology Review Course
Description This four-day intensive course is aimed at residents, fellows, and practicing ophthalmologists and will review the clinical essentials of each subspecialty in ophthalmology. It will be a clinically oriented review concentrating on the epidemiology,...Electrophysiology 2016: Diagnostics, Screening & New Testing Modalities
Description Visual electrophysiology is a powerful tool to assess the function of various components of the visual pathway system even. Even though it is often underutilized due to practical limitations, electrophysiology can improve your diagnosis and management of...Modernizing Medicine: Minimally Invasive Interventions in Ophthalmic Care
Description With modernization, surgical interventions in ophthalmology have become progressively more effective and simultaneously less invasive. Cataract surgery has moved from intracapsular extractions now to small incision femtosecond approaches. Glaucoma surgery...Eye on Ocular Inflammation: Pearls for the Ophthalmologist and Internist
Description Uveitis is one of the leading causes of preventable blindness in developed countries. It is crucial for physicians to understand how to best diagnose, differentiate and treat it. The fundamental management of this painful condition involves careful patient...47th Annual Doheny Days
Description The annual Doheny Days conference hosts dozens of presenters representing a wide range of ophthalmic specialties aimed at disseminating state-of-the-art research findings to improve clinicians’ ability to better diagnose and manage patients with...LOOK AHEAD: Apps & Eye Care
Doheny Eye Institute innovates alongside tech companies in a way that might be surprising to some. We identify gaps in care, and then collaborate with engineers on ideas for research, development and design for improved ophthalmologic treatment. Often, we are deeply involved from the earliest stages of device development and prototyping. We’ve worked closely with medical device imagineers for decades.
Luminaires Juniors Annual Benefit
Myths and Meanings: Adult Stem Cell Research
One of the great frontiers of research in the quest to improve eye health involves stem cells. It’s exciting, but the terms are often confusing, and even controversial. Because I see this research as a vital avenue for our patients, I want to use this space to explain precisely how we conduct this research at Doheny Eye Institute, using only adult stem cells, not embryonic stem cells.
Big Picture: Eye Care = Access
Many of us likely read with interest the recent story by Nicholas Kristof in the New York Times about the Nepalese ophthalmologist Dr. Sanduk Ruit, who cures blindness with a $50 cataract operation.
Fall 2015: Volume 33, No. 2
Fall 2015: Volume 33, No. 2 Featured in this issue: Dr. Alfredo Sadun The Eye in Alzheimer’s Disease The Doheny Eye Institute – UCLA Health System Affiliation The Best in the West Finding Answers Doheny’s Deming Sun Seeks an End to Inflammatory Eye...Phillip Le, MD, PhD
Phillip Le, MD, PhD i PubMed Office Locations Brochure Clinical Specialties Retinal and macular diseases Comprehensive ophthalmology Academic Degrees Bachelor of Science Massachusetts Institute of Technology Doctor of Medicine University of Pennsylvania Doctor of...A Genuine Game Changer: Injectable Treatment for Diabetic Retinopathy
The big news in November about the breakthrough in treatment of diabetic retinopathy deserves all the buzz and headlines it’s generating. The conclusive evidence that an injectable drug is just as effective, and not nearly as damaging, as the standard laser treatment favored since the 1970s is a game changer.
Vision for the Future: Gene Therapy is Here
At Doheny we are poised to begin providing patients with access to clinical trials of pioneering gene therapy any day now. It’s an advance that seems a perfect way to end the year, or begin the new one, with exciting innovation and hope for improved vision for many.
New Glaucoma Surgery Tailored to Each Patient’s Anatomy
Doheny Eye Institute’s Alex Huang, MD / PhD, has received a prestigious Research to Prevent Blindness Career Development Grant (2015). His work at the frontiers of customized surgery for glaucoma patients is poised to change approaches to treatment internationally. The impact of Dr. Huang’s work is more than global — listen to him talk about his pending research with NASA.
SriniVas R. Sadda, MD, named Speaker of the Day for Retina 2016!
Retina 2016 and the Administrator Program and Nurse & Allied Health Program of Hawaiian Eye kicked off Monday, joining the Comprehensive Ophthalmology Program which started Saturday.
Some Solutions Are Elegantly Low-Tech
I’m excited to share some important advances in the field that are the result of international collegial cooperation, intelligence and good humor. Tech can be magic, but in some cases, good old-fashioned talk is all that’s needed to move things forward.
Innovations and Entrepreneurship: Ideation to Commercialization (IEIC)
Description We will discuss the innovation process from ideation to commercialization in medicine, with experts in areas of intellectual property, business development, fund raising and FDA regulatory landscape and physician entrepreneurs. We aim to give valuable...Screening: Why Bother?
It’s just human nature to have a few items that don’t seem urgent forever stuck at the bottom of the to-do list. Screening for disease is like that. Feeling fine and not experiencing limitations or pain, we can all rationalize not looking for trouble.
Doheny 2017: 70 Years of Vision Research Leadership
Doheny Eye Institute has an international reputation as a premier research and clinical institution. This is truly a golden age for vision research at Doheny.
Thyroid Eye Disease, Aesthetics, & Global Standards
A conversation with Dr. Daniel Rootman: Thyroid eye disease, aesthetics, and moving toward global standards for orbital surgery.
Retina Research Across the Labs: Doheny + Jules Stein Eye Institutes at Work
Here at Doheny the benefits of joining forces with our colleagues at UCLA/Jules Stein Eye Institute are obvious to us every day. We appreciate the ability to collaborate and share research, and the very real advances we are making for patients.
Remembering Gordon Crary, Jr.
Gordon Crary, Jr, played an instrumental role in the growth of Doheny Eye Institute. He was deeply involved with Doheny for decades, going back to our formative years.
Doheny Annual Update – 2015
Doheny Annual Update Featured in this issue: Glaucoma 2015: Advances and Discoveries SriniVas Sadda, MD, Welcomed as President and Chief Scientific Officer Remembers Onnalee Doheny Celebrating Alumni at 2015 ARVO Reception Luminaires Founders CHapter: An Affaire to...Astronaut Scott Kelly’s Eyes May Offer Clues For Treating Disease
As NASA astronaut Scott Kelly returns to earth today after 340 days in space, and heads in for physical tests in Houston, ophthalmologists here on earth are eager to examine his eyes. “If you go up and stay a long time, many things start happening to the eye,” says Dr. Alex Huang.
Streamlining Screening is Next Big Advance
As the incidence of diabetes rises worldwide, we in eye care see ever increasing rates of retinal disease. This is disheartening and challenging, as diabetic retinopathy is usually asymptomatic until it’s pretty far along.
Streamlining Retina Screening
Dr. Tsui on streamlining retina screening, access to care + advances in pediatric retinopathy.
Land of the Blue Sky
Today, we are finally on our way thanks to travel funding provided by Virtue Foundation, embarking on an 18-hour journey to Beijing and then to Ulaanbaatar.
Asia-Pacific Academy of Ophthalmology
Later today I’ll fly to the Asia-Pacific Academy of Ophthalmology (APAO) annual conference in Taipei, Taiwan. I make the trip because I like to hear first-hand about the challenges and concerns our colleagues are facing in that region and to advance our collaborations across the region.
Welcome to Ulaanbaatar
We met with representatives from the ophthalmology service (which I can’t help but mention is run primarily by women!) and got started right away seeing patients. We saw over 50 pre-screened patients that our Mongolian colleagues had specially selected for our evaluation.
First Corneal Transplant at First Hospital
Two of my great loves are eye surgery and teaching. While I do both of these at home in Los Angeles, there is something uniquely fulfilling about teaching eye surgery in a foreign country. When I teach corneal transplantation in other countries, I become acutely aware of how incredibly fortunate I am to live in a time and place that makes my job as a corneal transplant surgeon possible.
The Butterfly Effect
Now that we have completed our surgeries and started training the Mongolian surgeons in cornea transplant techniques, it is time for an important part of our mission: teaching the Mongolian surgeons about corneal disease, in the classroom and in the practice lab.
Farewell Mongolia
Each time I do this, I ask myself why I volunteer for this stress, as if my day job back home isn’t already packed with challenging cases. But then I think about corneal blindness worldwide and see the eager faces of the doctors who desperately want to provide a surgical option to their patients.
Genius by Committee
In my three years as a member of the program committee for the retina section of the Association for Research in Vision and Ophthalmology, I’ve found the conventional wisdom that committee work kills inspired ideas seriously errant. I loved the work on behalf of ARVO, and as my term draws to a close, I’d like to reflect for a moment on what I found profoundly meaningful in the work — not just for me — but for science.
Remembering Richard L. Kasper, 1919-2016
Dr. Richard L Kasper passed away on March 29, 2016 at the age of 96. Dr. Kasper lived a long and fulfilled life dedicated to his Christian faith, his family, his medical profession and to his Armenian heritage.
Gene Therapy Today
Dr. Alfredo Sadun explains the latest advances and applications of gene therapy for treating diseases of the eye.
Mission to Mongolia
Last month, two of our colleagues, Dr. Olivia Lee and Dr. Laura Vickers, made an extraordinary trip to Mongolia, where they performed corneal transplant surgeries on several patients, including a three-month-old boy. The trip resulted in restored eyesight for many and an exchange of information between doctors that can mean so much for patients in the future.
29th International Congress of German Ophthalmic Surgeons
Robert K. Maloney, MD, MA, will be giving the annual Ridley Lecture at the 29th International Congress of German Ophthalmic Surgeons in June, 2016.
ARVO 2016 Conference Wrap Up + Recognitions
Over the past week, many of our Doheny doctors and scientists gathered with fellow researchers from around the world in Seattle for the annual conference of the Association for Research in Vision and Ophthalmology (ARVO). It was a great opportunity for all of us to reconnect with our extended Doheny family of physicians and researchers who have gone on to do important work all over the globe.
Mission to Mongolia
A conversation with Dr. Olivia Lee and Dr. Laura Vickers talking about their recent trip to Mongolia, where they performed six corneal transplant surgeries and trained colleagues in surgical techniques and follow up care.
ProgStar: Fighting Inherited Macular Degeneration in Young People
Doheny doctors treat patients with retinal disease daily; and we also work continuously with colleagues around the world to find ways to fight these diseases. I want to share a few insights about one of those important efforts —a study of Stargardt’s Disease called ProgStar, sponsored by the Foundation Fighting Blindness.
Doheny Eye Institute Names Renowned Interdisciplinary Program for Dr. Stephen J. Ryan
Originally the Beckman Initiative for Macular Research, Dr. Ryan founded the program with the support of the Arnold and Mabel Beckman Foundation.
Gene Therapy, Gene Editing and Curing Eye Disease
I am happy to use this space to offer more information on gene therapy and gene editing, which I consider to be one of the most exciting frontiers in treating eye disease.
Dr. SriniVas Sadda (Part 1)
On the frontiers of fighting eye disease: gene therapy, gene editing and innovations in imaging.
Dr. Michael Ip Joins Doheny Eye Institute
We’re pleased to announce the addition of Dr. Michael Ip. Dr. Ip, a retinal surgeon and researcher, will join the esteemed clinical care and clinical research teams at Doheny Eye Institute and the Doheny Image Reading Center (DIRC).
FIRST Retinal Stars
One of my enthusiasms across research areas is cultivating collaboration. I’m happy to say that for the youngest cohort of doctors in ophthalmology, collaborative work and communication skills are becoming part of the training in the field. Technology encourages this connectedness, but relational skills are also critical.
Dr. SriniVas Sadda (Part 2)
Advances in curing eye disease rely on collaborations and critical communication among colleagues around the globe.
Doheny Summer Update – 2016
Doheny Summer Update Featured in this issue: OCTA Opens a New Chapter in Ophthalmology Ultra-Widefield Imaging Reveals the Unknown Entrepreneur in Search of a Better Experience Aqueous Angiography: Going With The Flow Gene Therapy Trial for Leber’s Hereditary...Benjamin Bert, MD, FACS
Benjamin B. Bert, MD, FACS i PubMed Office Locations I Media Brochure Clinical Specialties Cornea/external diseases Acute corneal injury Uveitis Dry eye/blepharitis Conjunctivitis Genetic corneal disorders Comprehensive ophthalmology Refractive surgery Cataract...Michael S. Ip, MD
Michael S. Ip, MD i PubMed Office Locations Brochure Clinical Specialties Diabetic retinopathy Age-related macular degeneration Retinal Vein occlusion Vitreoretinal surgery Academic Degrees Bachelor of Science Tufts University Doctor of Medicine New York...Beaming Knowledge
One way in which technology is transforming ophthalmology that I find particularly encouraging is the inclusion of international colleagues in high-level training and discourse via live streams and webinars.
Dr. Brian Francis
Dr. Francis discusses the art and science of eye surgery, compassionate patient care and advances in nano-technology for eye patients.
View from Japan
My visit to Japan last month illustrated perfectly how vital our ties are to international colleagues.
In India, Talks About Diabetic Retinopathy Echo Internationally
Diabetes is epidemic in India, and soon, the country will be home to the largest diabetic population in the world. The concomitant increase in cases of diabetic retinopathy is alarming, making it one of the leading causes of blindness in the country. It seems that soon, the US will face similar issues. Globally, the implications for our work are enormous.
Doheny Research Reaches Quingdao Colleagues in Mandarin
In September, when Doheny’s Dr. Irena Tsui delivered a lecture in Mandarin to our colleagues at Quingdao Hospital at Nanjing University on the latest advances in fighting retinopathy of prematurity, I felt the legacy of our immediate past leader, Dr. Steven Ryan.
Glaucoma Update
Doheny fosters research at the frontiers of medical science, and, I am happy to say, we also foster expertise that can literally write the book on advances in treatment.
Election Extra! Now see this!
President-elect Donald Trump may just be intent on looking into the future. But it’s clear that he is often squinting. We asked Doheny Eye Institute Dr. John Irvine, a specialist in conditions of the cornea and external eye, to answer a couple of questions about issues for squinters.
Laurie Levin
A conversation with Laurie Levin, author of A Clear Vision, published in celebration of Doheny Eye Institute’s 70th Anniversary in 2017.
Imaging Update: Kudos to Dr. Vik Chopra for Innovative Applications
Throughout the year, I have the pleasure of using this space to call out the successes of my colleagues as they work to advance research and treatment in important and innovative ways.
Dr. Michael Ip
A conversation with Dr. Michael Ip, Medical Director of the Doheny Image Reading Center, about the critical importance of images, innovation and analysis in improving outcomes for eye patients.
US-China Cornea Forum Launched
The US-China Cornea Forum that took place during the American Academy of Ophthalmology fall conference in Chicago was a first. I’m happy to say the gathering was a direct result of Doheny’s enduring emphasis on international collaboration.
Your Vision for Doheny
When I share information in this space, I realize that I am dominating the conversation about advances and innovations at Doheny Eye Institute.
Ryan Legacy Strong in China
It was my honor to participate in the International Retina Conference at the distinguished Zhongshan Ophthalmic Center in southeast China. The Zhongshan Ophthalmic Center (ZOC) is a one of the best eye institutes in all of China and is a key partner and collaborator for the Doheny Eye Institute.
Out in Front on Zika
One of the hot topics among my colleagues in this new year is how to combat and treat the Zika virus, because there is now significant data now indicating that the virus affects the eyes of newborns, causing retinal lesions, and leaving large retinal scars that can damage vision.
Dr. Emily Chew
A conversation with Dr. Emily Chew, deputy director of the Division of Epidemiology and Clinical Applications and the deputy clinical director at the National Eye Institute at the National Institutes of Health. Dr. Chew directs studies about the links between diet and macular degeneration. She talks about those findings and other advances in the field.
Health Care: Continuity and Change
There is significant news about shifts in health care under the new Trump administration, so it is important to clarify that part of former President Obama’s health care legacy remains intact; and that remaining part affects our patients at Doheny.
Monica R. Khitri, MD
Monica R. Khitri, MD i PubMed Office Locations Brochure Clinical Specialties Pediatric eye exams Adult and pediatric strabismus Amblyopia Pediatric cataracts Pediatric glaucoma Congenital and pediatric ptosis Lacrimal duct surgery Eye muscle surgery Academic...Dr. Benjamin Bert
Dr. Bert is interested in convening conversations across medical disciplines, and is currently designing a trial to make patients undergoing injectable retina treatment more comfortable.
Doheny Eye Institute Sells Medical Office Building
Doheny Eye Institute, one of the world’s leading, nonprofit visionresearch organizations, announces the sale of its medical office building at 1450 San Pablo Street in Los Angeles to the University of Southern California. The property is encircled by USC’s health sciences campus.
Dr. Monica Khitri
A conversation with Dr. Monica Khitri about treatment for the very youngest of children facing compromised vision and eye health challenges. Dr. Khitri discusses surgery options for infants, eyeglasses for toddlers, and her work guiding parents in making choices for their child’s eye care.
Eyes Wide Open: Stem Cell Therapy Patients Confront Promise, and Peril
I want to share a few thoughts regarding the recent stories about three elderly patients in Florida who hoped to slow the decline of their vision due to macular degeneration by opting for stem cell injections to the eye. Instead of enjoying restored vision, they wound up blind.
Innovations & Entrepreneurship: Ideation to Commercialization
Description Course Director: Kenneth Lu, MD We will discuss the innovation process from ideation to commercialization in medicine with experts in all areas of the innovation process. Participants will be able to distinguish basic tenets in the process of ophthalmic...Doheny Society of Scholars & Alumni Meeting: Clinical Challenges
Description Course Directors: Peter Quiros, MD, SriniVas Sadda, MD, John Irvine, MD and Hugo Hsu, MD The Doheny Society of Scholars was established to recognize the academic achievements and professional contributions of Doheny alumni. Please join us for a full day...Evolving Imaging and Treatment Modalities for Retinal Disease
Description Course Director: Michael Ip, MD This course will update practicing ophthalmologists and related health-care professionals on recent advances and controversies in the management of a variety of posterior segment disorders. Objectives Z Introduce...Doheny Eye Institute Researcher Voted World’s Top Ophthalmologist
Doheny Eye Institute’s Alex Huang, MD, PhD, is #1 on The Ophthalmologist magazine’s Power List 2017, a ranking of the most influential people in the field. This year’s rankings focused on the “rising stars” of ophthalmology. Young leaders in ophthalmology were nominated by colleagues, and an expert panel made the final selections to create the annual list.
ARVO 2017
This year at ARVO we’ll convene the first-ever India Forum. The reasons for doing this now are grounded in a keen desire to further reinforce existing connections in India – both to make the most of our Doheny fellows network and on-going collaborations and to invite new opportunities for cooperation.
Dr. SriniVas Sadda given the 2017 ASRS Presidents’ Retina Young Investigator Award
The 2017 Young Investigator Award recipient, SriniVas R. Sadda, MD, is the President and Chief Scientific Officer of the Doheny Eye Institute, the Stephen J. Ryan – Arnold and Mabel Beckman Endowed Chair, and Professor of Ophthalmology at the University of California – Los Angeles (UCLA), David Geffen School of Medicine.
Dr. John Irvine
A conversation with Dr. John Irvine about topics and presenters featured at this year’s Doheny Days gathering, and the enduring relevance of Continuing Medical Education as critical to informing the work of ophthalmologists at the frontiers of research and patient care.
Seeing the Bottom Line
The much anticipated results of a trial of two drugs used to treat retinal vein occlusion were revealed at the annual Association for Research and Vision in Ophthalmology (ARVO) conference in May, and the news has important implications.
Dr. Kenneth Lu
A conversation with Dr. Kenneth Lu, a cataract surgeon, and founder of the Doheny Innovation and Entrepreneurship Conference, helping innovators in vision care bring their ideas out of the lab and into the marketplace.
Gallery: 48th Annual Doheny Days
Gallery of our 48th Annual Doheny Days
2017 Doheny Annual Update
Featured in this issue: The Doheny Eye Institute Coffee Table Book, Luminaires Founders Passion for Fashion, Luminaires Jrs. Shake It Up for Doheny Eye Institute, Three New Members Join Doheny Eye Institute’s Board of Directors, Planned Giving Donor John J. Shaak Knows the Risk of Losing Vision
Donor Reception at Bighorn Golf Club
Description Donors to Doheny Eye Institute are invited to a reception on January 11 at the Bighorn Golf Club in Palm Desert. Doheny’s President and Chief Scientific Officer, Dr. SriniVas Sadda, discuss age-related macular degeneration and Doheny’s efforts to find...Janet DeMint
A conversation with Janet DeMint, director of the Ryan Initiative for Macular Research, a program of the Doheny Eye Institute. DeMint describes the impact the Initiative is having by bringing together scientists with expertise in ophthalmology, stem cell research, and a range of other specialties, resulting hundreds of millions of dollars of funding for interdisciplinary research to cure macular degeneration.
Encore Edition
Hear two of our most-listened-to episodes in this one encore edition. First, Dr. Olivia Lee and Dr. Laura Vickers share insights from their mission to Mongolia, where they trained colleagues in corneal transplants. Plus, a conversation with Dr. Alfredo Sadun, about advances in gene therapy, and his on-going international research in the quest to cure Leber’s Hereditary Optic Neuropathy.
Annual Doheny-UCLA International Glaucoma Symposium
2017 Doheny Summer Update
Featured in this issue: Key Successes That Secured Our Future, Glaucoma, Nasa, and Doheny’s Amazing Dr. Alex Huang, A Stem Model Leading The Doheny Image Analysis Laboratory
IRIS: A New Look at Science and Engineering Advances
Doheny Eye Institute and UCLA /Jules Stein Eye Institute have collaborated to support the launch of the International Retinal Imaging Society, or IRIS. At our first IRIS Executive Committee meeting in Italy in early July, we explored the scope of our work and our goals together.
Ranked #1 in California
Dr. Anne Coleman
A conversation with Dr. Anne Coleman of the Stein Eye Institute. Her work addresses issues faced by special populations, including children who visit the UCLA Mobile Eye Clinic, which she directs. Dr. Coleman is also focused on slowing the progression of macular degeneration, a disease which affects elderly patients.
Annual Alumni Reception
Description Please mark your calendars on Sunday, November 12, 2017 for our annual alumni reception at the AAO annual meeting in New Orleans. Reconnect with friends and colleagues for what promises to be a fun...Gallery: Donor Appreciation Event
Gallery of our Fourth Annual Donor Appreciation Event
Gallery: Festive Fall Fundraiser
Gallery of our Festive Fall Fundraiser.
Why Big Data is a Big Deal
The work of the Doheny Imaging Reading Center (DIRC) here at the Doheny Eye Institute can be very personally meaningful –for patients we treat here, and for those patients around the world whose images we analyze.
Field Study in Rural Brazil
Dr. Alex Huang
A conversation with Dr. Alex Huang, a convener of the 2nd Annual Doheny-UCLA International Glaucoma Symposium in Los Angeles coming up in October. We discuss hot topics in glaucoma research, and the dynamic regulatory environment. Plus insights into Dr. Huang’s own research, including his collaboration with NASA. Dr. Huang was voted the top ophthalmologist in the world by his peers in 2017.
New Frontiers in Imaging
Description Imaging is an essential element in the diagnosis and management of eye disease. Advances in the field have come at a rapid pace. At this meeting, we will review recent developments and discuss the latest applications and techniques in imaging technology....Doheny at AAO
2018 Alumni Dinner
Distinguished Alumnus J. Timothy Stout, MD, PhD, MBA Dr. Tim Stout is the Chairman of the Ophthalmology Department and Director of the Cullen Eye Institute at Baylor College of Medicine (BCM) in Houston, Texas since 2013. Prior to this position, Dr. Stout served as...How Breakthroughs Happen
The work of the Doheny Imaging Reading Center (DIRC) here at the Doheny Eye Institute can be very personally meaningful –for patients we treat here, and for those patients around the world whose images we analyze.
Engaging OCTA in Glaucoma Imaging
Gallery: Annual Glaucoma Symposium
Gallery of our Annual Glaucoma Symposium.
Dr. Hugo Hsu
A conversation with Dr. Hugo Hsu. Dr. Hsu is an accomplished cornea specialist in his work with patients. Now, he is on the cusp of some very innovative research in the microbiome of the eye’s surface, looking for more clues to curing eye disease.
Gallery: Doheny at AAO
Gallery of Doheny at AAO
Artificial Intelligence: We’re All In
The real and exciting advances that AI offers in medicine matter because they mean we can more quickly diagnose, and precisely treat, our patients.
Dr. Tara McCannel
A conversation with ocular cancer specialist Dr. Tara McCannel, Director of the Ophthalmic Oncology Center at UCLA Stein Eye Institute. Dr. McCannel discusses the evolving technology allowing for earlier detection of small cancers, and how UCLA doctors developed procedures to significantly improve outcomes for patients treated with radiation for melanomas of the eye.
Gallery: Doheny Holiday Reception
Gallery of our Doheny Holiday Reception.
Gallery: Media Hard Hat Tour
Gallery of our Media Hard Hat Tour of 150 N. Orange Grove, Pasadena.
Help Us Make a Positive Impact
Gallery: Society of Scholars & Alumni Dinner
Gallery of our Society of Scholars event.
Vikas Chopra, MD, Awarded Warren Endowed Chair
Doheny Eye Institute is proud to announce that Vikas Chopra, MD has been awarded the Charles Stewart Warren and Hildegard Warren Endowed Research Chair.
Dr. David Sarraf
A conversation about emerging imaging technologies in vision care with Dr. David Sarraf of the UCLA Stein Eye Institute.
Deming Sun, MD, Awarded Endowed Research Chair
Doheny Eye Institute is proud to announce that Deming Sun, MD has been awarded the Mary D. Allen Endowed Chair in Vision Research. This prestigious faculty position is supported by the generous gift made to the Institute by Mrs. Allen in 1990.
Sight is Priceless
As our population ages here in the US, support for vision care research must grow so our patients can benefit from accelerated research, earlier diagnosis, and effective interventions and therapies.
The Black and White Ball
A conversation with James Jorkasky & Dr. Alex Huang
A conversation about vision science research funding with James Jorkasky, Executive Director of the National Alliance of Eye and Vision Research in Washington, D.C., and Doheny Dr. Alex Huang.
Eyes On Screens: What it Means for Vision Health
The latest research demonstrates the negative effects of excessive screen time on our eye health.
2018 Doheny Annual Update
Featured in this issue: Message from the President and Executive Director, Score 2 Study and Translating Studies into Treatment – featuring Michael Ip, MD, Finding signs of Zika virus in infant eyes – featuring Irena Tsui, MD
Luminaires Founders Annual Benefit
Gallery of our Luminaires Founders Annual Benefit.
Mission to Mexico
Dr. Francis discusses his visit to Fuerte, Mexico, where he performed dozens of pro bono surgeries for patients at a rural clinic.
A conversation with Ken Marion
A conversation with Ken Marion, Program Manager at the Doheny Image Reading Center Research Lab. Insights into how Doheny collaborates with medical device makers and other industry innovators, conducts state of the art imaging research and hosts an international cohort of leading ophthalmologists working to advance vision research.
AI + 5G = Surgical Advances
Artificial intelligence enabled robotic assistance in surgery has the potential to revolutionize ophthalmologic care in the future.
Black & White Ball: Photo Booth
Gallery of the Luminaires Juniors Photo Booth, from the Black & White Ball.
Gallery: Black & White Ball
Gallery of the Black & White Ball, presented by the Luminaires Juniors.
Doheny Eye Institute Announces New Headquarters in Pasadena
Doheny Eye Institute, a top-ranked nonprofit organization proudly affiliated with UCLA Stein Eye Institute and dedicated to furthering the conservation, improvement and restoration of human eyesight since 1947, is pleased to announce the purchase of its new headquarters in Pasadena.
3rd Annual Doheny-UCLA International Glaucoma Symposium
Description Course Director: Alex Huang, MD, PhD The course material will be a combination of anterior and posterior segment clinical scenarios, translational research, and bench investigation. Topics Include: Glaucoma pharmaceuticals (including new FDA-approved...What’s New in Neuro-Ophthalmology: Same Diseases, New Tests and Treatments
Description Course Director: Peter Quiros, MD This half-day course draws upon the experience of UCLA neuro-ophthalmologists and invited speakers in the review and analysis of the latest developments in the diagnosis and management of various neuro-ophthalmic...The Annual UCLA (DEI/SEI) Comprehensive Ophthalmology Review Course
Description Course Director: John Irvine, MD, Sherwin Isenberg, MD This four day intensive course is aimed at residents, fellows, and practicing ophthalmologists. It will review the clinical essentials of each subspecialty in ophthalmology. It will be a clinically...The Crowd: Luminaires raise funds for Doheny Eye Institute
Doheny Eye Institute of Southern California receives local support during its 43rd annual spring benefit raising over $110000.
Ryan Initiative Update
Many of us recently came together for several days of study and conversation as part of the 10th Anniversary conference of the Stephen J. Ryan Initiative for Macular Research.
New Huntington Biomed Lab in Pasadena Seen as Hub for Research, Collaboration
The bioscience center will potentially serve as a hub for research and clinical collaboration with Doheny Eye Institute, UCLA and California Institute of Technology.
Doheny’s Collaboration with NASA Leads to Cutting Edge Vision Testing Technology in Space
NASA launched the SPECTRALIS with OCT2 Module to the ISS aboard the Antares 230 Cygnus CRS OA-9, also known as Orbital Sciences CRS Flight 9E on May 21, 2018 from Wallops Island, Virginia. The device will be installed on the ISS in late 2018.
Low Vision And Aging In Place Conference
On July 18, Braille Institute Los Angeles is hosting a low vision conference featuring speakers from Doheny Eye Institute on aging in place with low vision.
Exceptional Outcome for Cornea Transplant Patient
How one savvy patient partnered with a Doheny doctor to pursue cutting edge treatment to save her sight. A conversation with television producer Lauren Dascher, and Dr. Olivia Lee.
Zurich News & NASA Notes
This spring and early summer, gatherings and collaborations have kept me moving and thinking about what most accelerates research.
Annual Donor Appreciation Reception
Join us in celebrating you! We are very grateful for your generosity and support which allows us to pursue our mission to preserve, conserve and restore human eyesight. Be among the first to see Doheny’s future home in beautiful Pasadena, The City of Roses, and...Doheny & Stein Alumni Reception at AAO
Description Please join us in Chicago during the annual AAO meeting for the Doheny and UCLA Stein Eye Institutes Alumni Reception. RSVP today to attend to reconnect with colleagues and friends....3rd Annual US-China Cornea Symposium at AAO
Description As medical professionals in the US and a responsible global citizens, there is a critical need to share our work and collaborate with other nations in an international effort to improve the quality of eye care everywhere. At the 3rd Annual US-China Cornea...Emerging Trends and Hot Topics in Ophthalmology at AAO
Description Join us for a delicious breakfast and presentations from Doheny and UCLA Stein Eye Institute physicians on the latest and most innovative research and clinical findings in ophthalmology. We will give an overview of the most relevant and promising research...2019 Doheny & Stein Alumni Reception at ARVO
Register...Gallery: Donor Appreciation Event
Gallery of our Donor Appreciation Event.
Connect and Assess: Two critical constants in improving vision science
The world-class training and infrastructure in Singapore’s health care stays relevant with constant fine-tuning.
Advances in technology can enhance patient care globally
David Garway-Heath, MD, FRCOphth, President of the European Glaucoma Society, and Alex Huang, MD, PhD discuss how advances in technology and collaboration continuously enhance patient care globally.
Gallery: AAO Alumni Reception
Gallery of our AAO Alumni Reception.
Gallery: Welcome Reception
Gallery of our Welcome Reception for Steven Barnes, PhD & Yuhua Zhang, PhD
The Quest to Cure Age-Related Macular Degeneration (AMD)
Our determined focus to understand and eliminate this disease is a priority at Doheny, as well as at many of our peer institutions.
Help Us Make a Positive Impact
Steven Barnes, PhD, shares how physicians will deliver earlier treatments for those with retinal disease.
Dr. Barnes shares how the cells in the retina are vital to show disease and its progression. His work to study these cells and the signals they provide will allow physicians to deliver earlier treatments for those with retinal disease.
Advancing Research: Samuel Asanad, winner of the 2018 RPB award
In 2018, Samuel Asanad was one of three medical students across the U.S. to receive the Jules Stein Research to Prevent Blindness (RPB) Eye Research Fellowship under the mentorship of Doheny neuro-ophthalmologist, Dr. Alfredo A. Sadun, at Doheny-UCLA, and director of neuroscience, Dr. Michael Harrington, at the Huntington Medical Research Institute (HMRI).
Newest therapies, drug delivery options, and the best ways to get involved with stem cell trials.
A conversation with Dr. Ali Khan about the newest therapies, and drug delivery options for patients with wet Age-related Macular Degeneration, and the best ways to get involved with stem cell trials.
2019: Looking Forward
This year in vision science we expect more breakthroughs and new collaborations – all pointing toward hope for our patients.
Applying Old Solutions to New Technology
As we look ahead, there is great anticipation to the many advances in the field of vision science that we know are on the near horizon.
Ideal Candidates For Clinical Trials
A conversation about clinical trials with Dr. Alfredo Sadun. Patients in treatment often ask about participation in these drug tests. Dr. Sadun explains how doctors and researchers decide who makes a good candidate for a clinical trial, how to ensure a trial is legitimate, and the impact of clinical trial research on his own work throughout his career in neuro-ophthalmology.
Doheny Campus Update
As we look ahead, there is great anticipation to the many advances in the field of vision science that we know are on the near horizon.
Gallery: Society of Scholars & Alumni Meeting
Gallery of our Society of Scholars & Alumni Meeting
Gallery: 2019 Doheny Alumni Dinner
Gallery of our 2019 Doheny Alumni Dinner
Artificial Intelligence (AI) at Doheny
Artificial Intelligence (AI) at Doheny: Learn about AI as an emerging and exciting tool to aid in diagnosing ocular disease as well as its capabilities to link disease prevention, treatment and patient outcomes.
4th Annual Doheny-UCLA International Glaucoma Symposium
Description Course Director: Alex Huang, MD, PhD The 4th Annual Doheny-UCLA International Glaucoma Symposium brings together experts in glaucoma to better define current challenges and initiate discovery of innovative solutions. The course material will be a...Cornea: Clinical Review and Updates
Description Course Director: Hugo Hsu, MD This course aims to provide a review and update for general ophthalmologists on diagnostic and treatment modalities for a variety of cornea and related disorders. Emphasis will be placed on presenting and reviewing the...ARVO, AI, and a Vision for the Future
It seems entirely accurate to me when my Doheny colleague, Dr. Alfredo Sadun, says that in his assessment, the impact of AI on medicine will be as sweeping as the impact of the industrial revolution on the world.
C.U.R.E. Ride
The 11th annual C.U.R.E. Ride takes place from August 24-25, 2019. It is a two-day bicycle ride from Hermosa Beach to San Diego spearheaded by Jeremy Poincenot and his mother, Lissa Poincenot. All donations to the 2019 C.U.R.E. Ride will support LHON research at...Support LHON Research at Doheny
The 3rd annual Shades for Sage fundraiser will be held on Saturday, July 27, 2019 in Huntsville, Alabama. The event includes music, food, an opportunity drawing, and silent auction. All funds raised at the event will be used to further LHON research. Sage Lyons was...The Doheny-UCLA Retina Symposium: Update for 2020
Description Course Director: Michael Ip, MD The Doheny-UCLA Retina Symposium is designed to be a full-day course that brings together world-renowned experts in retina to better define current challenges and initiate the discovery of innovative solutions Register View...Annual Donor Appreciation Reception
Description Through your kindness and generosity, Doheny continues to pursue our mission to preserve, restore and conserve the precious gift of sight. We invite our donors to join us in celebrating the impact your support has made towards vision research. Spend a...Doheny & Stein Alumni Reception at AAO
Description Join us for the Alumni Reception during the 2019 AAO Annual Meeting hosted by the Doheny Professional Alumni Association and the UCLA Stein Eye Institute Alumni Association. Kindly RSVP by October 4,...Collaborations & Conversations
It seems entirely accurate to me when my Doheny colleague, Dr. Alfredo Sadun, says that in his assessment, the impact of AI on medicine will be as sweeping as the impact of the industrial revolution on the world.
Reflecting on Five Years of Doheny – Stein Partnership
Our collaborations with UCLA Stein faculty continue to flourish and constantly provide us new avenues to explore in vision research.
Alumni Conference – To Be Rescheduled
The Alumni conference is designated to Alumni and UCLA faculty who will present on state-of-the-art research findings to improve clinicians’ ability to better diagnose diseases in ophthalmology. Our presenters are forefront physician-scientists who will be speaking on a wide range of ophthalmic specialties.
Doheny Breakfast Forum: New Horizons in Artificial Intelligence
Description Join us as a panel of world renowned experts in AI in ophthalmology present the current status of AI applications in clinical and research ophthalmology and discuss its capabilities and future use across all ophthalmic specialties. Register Speakers...Corneal Cross-Linking and its Potential Promise
A conversation with Dr. Benjamin Bert, and Doheny-UCLA clinical fellow, Dr. Arpine Barsegian about corneal collagen cross-linking, a breakthrough procedure for patients with thinning corneas.
NASA Selects Doheny Proposal to Support Astronaut Vision Health
Alex Huang, Assistant Professor at Doheny Eye Institute, will explore the use of aerobic exercise and venous thigh cuff inflation as a countermeasure to SANS.
2020 Alumni Dinner – To Be Rescheduled
s Notice: Event to be rescheduled to a later date. Description Doheny Eye Institute invites you to attend the Alumni Dinner honoring Mark Borchert, MD as our 2020 Distinguished Alumnus. Join us at the beautiful Jonathan Club in downtown Los Angeles immediately...4th Annual US-China Cornea Symposium
Description As medical professionals in the US and as responsible global citizens, there is a critical need to share our work and collaborate with other nations in an international effort to improve the quality of eye care everywhere. At the 4th Annual US-China Cornea...Advancing Diagnostics for Glaucoma and Retinal Disease with AI
A conversation with Dr. Alex Huang, Doheny-UCLA research-scientist, and Dr. Naama Hammel, Clinical Research Scientist at Google Artificial Intelligence Healthcare.
Scaling Successes in Saving Sight
One of the successes we’ve seen in ophthalmology and vision research, particularly in advancing the treatment of diabetic retinopathy, is the collaborative approach taken by the DRCR Retina Network collaboration.
Gallery: Donor Appreciation Reception
Gallery of our Donor Appreciation Reception.
Charles T. Foscue Elected Chairman of the Doheny Eye Institute Board of Directors
Doheny Eye Institute has announced that Charles T. (Tom) Foscue has been elected as Chairman of the DEI Board of Directors.
Doheny and UCLA Stein Eye Institutes Welcome Kaustabh Ghosh, PhD, to the Scientific and Clinical Research Faculty
Doheny and UCLA Stein Eye Institutes proudly welcome Kaustabh Ghosh, PhD, to the scientific faculty as Associate Professor in basic science at the UCLA David Geffen School of Medicine.
Gallery: 4th Annual Doheny-UCLA International Glaucoma Symposium
Gallery of our Gallery: 4th Annual Doheny-UCLA International Glaucoma Symposium.
Give the Gift of Sight This Holiday Season
Innovations in the Treatment of Polypoidal Choroidal Vasculopathy
A conversation with Dr. Micheal Ip, Director of the Doheny Image Reading Center, and Dr. Gemmy Cheung, head of the Retina Research Group at the Singapore Eye Research Institute.
Collaboration for Promising Outcomes
One aspect of the doctor-patient relationship that matters profoundly, but that is often overlooked, is storytelling.
2020 Summer InSight Newsletter
Featured in this issue: Preserving Vision on Missions to Mars, Retina Team Looks for Continued Breakthroughs, Dr. Sadun at the Forefront of LHON Research
AI Screening: Allowing Physicians to See Eyes More Clearly from Afar
The Doheny-UCLA Retina Symposium
Gallery of our Doheny-UCLA Retina Symposium.
Pioneering Study Important for Expectant Mothers
We are fortunate that our diverse and accomplished physicians are invested in defining the cutting-edge of treatment options.
Treating Cancer Patients with Eye Disease
In this conversation, Dr. Olivia Lee and Dr. John Irvine discuss the collaboration between Doheny Eye Institute and City of Hope, consulting on graft-vs-host disease (GVHD) in patients suffering from symptoms that affect their eyesight.
Luminaires Founders Annual Benefit
Gallery of our Luminaires Founders Annual Benefit.
Congratulations to Doheny’s Dr. Alex Huang for placing in The Ophthalmologist’s Power List 2020
Health Care is Global: Coronavirus Illuminates both Concerns, and Connections
Working together is what will allow us to find cures.
Dr. SriniVas Sadda and Dr. Deborah Ferrington
A conversation with Doheny Eye Institute’s Dr. Vas Sadda and Dr. Deborah Ferrington about the work of the Ryan Initiative for Macular Research ahead of RIMR’s 12th annual conference.
The Fragile Eyesight of Premature Babies
A conversation with Irena Tsui, MD of Doheny-UCLA and Alison Chu, MD, neonatologist at UCLA about preserving the fragile eyesight of premature babies.
COVID-19, Research, and Healthcare
We remain focused on our mission with determination.
July 2020
Construction Update: 7.27.2020Construction Update: 7.27.2020
Photos from the very first day of work on the future home of DEI at 150 North Orange Grove in Pasadena, California.
July 2020
Construction Update: 7.30.2020Construction Update: 7.30.2020
Set-up of the construction trailer began.
Justin Karlin, MD, MS
Justin Karlin, MD, MS i PubMed Office Locations Clinical Specialties Oculoplastics Academic Degrees Master of Science California State University, Northridge Doctor of Medicine Sackler School of Medicine Residency Ophthalmology University of Virginia Internships...Victoria Tseng, MD, PhD
Victoria Tseng, MD, PhD i PubMed Office Locations Clinical Specialties Glaucoma Academic Degrees Doctor of Medicine Warren Alpert Medical School of Brown University Doctor of Philosophy UCLA Fielding School of Public Health Residency Ophthalmology UCLA Stein Eye...August 2020
Construction Update: 8.16.2020Steady Advances in Vision Science Research
Early stage detection can point us towards treatments that may arrest or eliminate disease progress.
October 2020
Construction Update: 10.11.2020Christine V. Nguyen, MD
Christine V. Nguyen, MD i PubMed Office Locations Clinical Specialties Cataract and Glaucoma Surgery Academic Degrees Doctor of Medicine Georgetown University School of Medicine Residency Ophthalmology Gavin Herbert Eye Institute Fellowships Glaucoma Division Doheny...Victoria H. Yom, MD
Victoria H. Yom, MD i PubMed Office Locations Clinical Specialties Corneal & External Diseases Academic Degrees Doctor of Medicine Washington University School of Medicine Residency Ophthalmology and Visual Sciences Washington University School of Medicine Board...October 2020
Construction Update: 10.25.2020Dr. Anne Coleman
The Doheny Podcast Network returns with this conversation with glaucoma specialist Dr. Anne Coleman of UCLA Stein Eye Institute. Dr. Coleman talks about her year as President of the American Academy of Ophthalmology, and as the COVID-19 pandemic unfolds, how it is affecting patients, doctors and vision science research.
November 2020
Construction Update: 11.08.2020November 2020
Construction Update: 11.15.2020November 2020
Construction Update: 11.29.2020Kaustabh Ghosh, PhD
Kaustabh Ghosh, PhD Principal InvestigatorAssociate Professor of OphthalmologyDavid Geffen School of Medicine, UCLADoheny Eye Institute PubMed Lab i CV Academic Degrees Bachelor of Technology National Institute of Technology, Warangal, India Master of Science...MinHee K. Ko, PhD
MinHee K. Ko, PhD Research ScientistDoheny Eye Institute PubMed i CV Academic Degrees Bachelor of Science YeongNam University, Republic of Korea Master of Science Chungnam National University, Republic of Korea Doctor of Philosophy University of Southern California,...Deming Sun, MD
Deming Sun, MD Mary D. Allen Endowed Chair in Vision ResearchPrincipal InvestigatorProfessor, Department of OphthalmologyDavid Geffen School of Medicine, UCLADoheny Eye Institute PubMed Lab i CV Academic Degrees Doctor of Medicine Albert-Ludwig Universitat,...Steven Barnes, PhD
Steven Barnes, PhD Principal InvestigatorProfessor, Departments of Ophthalmology and NeurobiologyDavid Geffen School of Medicine, UCLADoheny Eye Institute PubMed Lab Academic Degrees Bachelor of Arts Biophysics, University of California, Berkeley Doctor of...Ram Kannan, PhD, FARVO
Ram Kannan, PhD, FARVO Principal InvestigatorAdjunct Professor of OphthalmologyDavid Geffen School of Medicine, UCLADoheny Eye Institute PubMed Lab i CV Academic Degrees Bachelor of Science Chemistry, Osmania University, Hyderabad, India Master of Science Organic...Yuhua Zhang, PhD
Yuhua Zhang, PhD Principal InvestigatorProfessor of OphthalmologyDavid Geffen School of Medicine, UCLADoheny Eye Institute PubMed Lab i CV Academic Degrees Bachelor of Science Precision Instrument Engineering, Tianjin University, China Master of Science Optical...Dr. Kaustabh Ghosh
In this episode of the Doheny Podcast Network, a conversation with Doheny researcher, Dr. Kaustabh Ghosh. He talks about his expertise in biomechanics and how tackling big questions in cardiac care led him to ophthalmology, where he is leading an innovative lab.
Test
Construction Update: 8.16.2020
Construction Update: 8.16.2020 In August 2020, DEI broke ground on its future headquarters at 150 North Orange Grove in Pasadena. This new facility will include the headquarters for Doheny Eye Center UCLA, an outpatient surgery center, and expanded vision research...Construction Update: 10.11.2020
Construction Update: 10.11.2020 OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA Photos Courtesy of Bill...Construction Update: 10.25.2020
Construction Update: 10.25.2020 OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA Photos Courtesy of Bill...Construction Update: 11.08.2020
Construction Update: 11.08.2020 OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA...Construction Update: 11.15.2020
Construction Update: 11.29.2020
Construction Update: 11.29.2020 OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA OLYMPUS DIGITAL CAMERA Photos Courtesy of Bill...Zhihong (Jewel) Hu, PhD, ECE
Zhihong (Jewel) Hu, PhD, ECE Research ScientistDoheny Eye Institute PubMed Lab Academic Degrees Doctor of Philosophy Electrical & Computer Engineering, University of Iowa Research Interests Dr. Hu leads the Doheny Eye Image Analysis Laboratory (DIAL) for the...2021 Summer InSight Newsletter
Featured in this issue: New Campus Progresses, Connecting the Dots – Interdisciplinary Science Guides Vascular Research, Glaucoma Success–A Team Effort, Dr. Sun Seeks Disease Triggers
Doheny & Stein Alumni Reception at AAO
Join us for the Alumni Reception during the 2021 AAO Annual Meeting hosted by the Doheny Professional Alumni Association and the UCLA Ophthalmology Alumni Association.
Research to Prevent Blindness Awards Doheny Researcher, Yuhua Zhang, PhD
Doheny-UCLA researcher, Yuhua Zhang, PhD, is the most recent recipient of the Catalyst Award from Research to Prevent Blindness
Deborah Ferrington, PhD, Announced as Chief Scientific Officer
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Deborah Ferrington, PhD, is joining the organization as Chief Scientific Officer (CSO)
Jane W. Chan, MD
Jane W. Chan, MD i PubMed Office Locations Clinical Specialties Neuro-ophthalmology Optic nerve, optic neuropathies (PION, AION, TON) Toxic and nutritional optic neuropathies Optic Neuritis CNS Infectious Disease Thyroid Eye Disease Pupillary Disorders Ischemic...Kirk Hou, MD, PhD
Kirk Hou, MD, PhD i PubMed Office Locations Clinical Specialties Diabetic retinopathy Age-related macular degeneration Retinal vein occlusion Vitreoretinal surgery Academic Degrees Bachelor of Science and Engineering Princeton University, NJ Doctor of Medicine...A Tale of Two Drugs: Developing Novel Therapeutics to Treat Glaucoma – Michael Fautsch, PhD
Dr. Michael Fautsch is the Joseph E. and Rose Marie Green Professor of Visual Sciences, 2020 and Research Chair, Department of Ophthalmology at the Mayo Clinic, Rochester, MN. His laboratory team is identifying new therapeutic targets and developing novel therapeutics to regulate pressure and preserve the function of the optic nerve, the ultimate site of eye damage leading to vision loss in glaucoma.
UCLA Department of Ophthalmology Annual Seminar
The UCLA Department of Ophthalmology Annual Seminar is designed as an update course covering current clinical and research aspects of each of the ophthalmic subspecialties. The 1.5 day program includes the full-time faculties of both the Stein Eye Institute and the Doheny Eye Institute, along with nationally prominent invited lecturers.
Distinguished Lecture Series – OCT Angiography and Beyond
Optical coherence tomographic angiography (OCTA) is the most important new clinical OCT technology in the past decade. It became available as a clinical instrument in 2014. Since then it has been applied to a wide range of retinal and optic nerve diseases. This presentation will review the current state of the art and key clinical applications. I will also report on the development of several novel OCT technologies in our laboratory that may have important clinical applications in the near future.
Inside Out: Relations Between the Microbiome, Eye Health and Diabetic Retinopathy – Maria Grant, MD, FARVO
Dr. Maria Grant is the Eivor and Alston Callahan, M.D., Endowed Chair in Ophthalmology and Professor, Department of Ophthalmology and Visual Sciences, at the University of Alabama at Birmingham School of Medicine. Most recently, she has worked on understanding the interactions between the gut microbiome, plasma microbiome, and bacterial derived peptides and metabolites on diseases of the eye and on pathogenesis of severe COVID infection.
Doheny Eye Institute Celebrates New Headquarters in Pasadena
The event welcomed over 350 attendees from the community, elected officials and invited guests with speeches from Doheny CEO, Marissa Goldberg, UCLA Representatives and City of Pasadena Mayor Victor Gordo welcoming Doheny Eye Institute to the community.
World Ophthalmology Congress 2022
The 38th World Ophthalmology Congress of the International Council of Ophthalmology will take place online from 9 to 12 September 2022. During 4 science-packed days, top experts in all fields of ophthalmology will connect from around the globe to shape the future of eye care. The program will feature 175 innovative sessions and an average of 10 hours of live and engaging content per day!
Alliance for Eye and Vision Research Emerging Vision Scientist Program
The Alliance for Eye and Vision Research (AEVR) has announced a series of virtual events on Sept. 23 that are associated with International Age-Related Macular Degeneration (AMD) Awareness Week 2020 and AEVR’s Sixth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill.
Annual Congress of the European Association for Vision and Eye Research (EVER)
The European Association for Vision and Eye Research (EVER) congress is a site for clinicians and scientists to discuss their latest advances, and to encourage the participation of young ophthalmologists and visual scientists, as they are undoubtedly the future of our society. Sharing knowledge is usually the main purpose of the Congress, but this year we also need to re-launch the society encouraging the participation of students, residents in training and young investigators.
Frontiers in Optics + Laser Science
In a time of technological disruption and evolution, when even things as familiar as vision, computers and automobiles seem to be on the edge of amazing reinvention, FiO LS brings forward true visionaries to speak about discoveries soon to come.
OPTICA Fall Vision Meeting
The Fall Vision Meeting is a small, high quality, international meeting sponsored by Optica for researchers in visual neuroscience, optics and psychophysics. The small and focused nature of the meeting and its single-track format foster active discussion and often forge friendships and collaborations.
SPIE/COS Photonics Asia 2022
This annual symposium continues to be held in partnership between SPIE and COS—Chinese Optical Society, providing an international showcase for the latest research in biomedical optics, advanced optical imaging, quantum and nonlinear optics, laser processing, plasmonics, holography, and more.
The Retina Society Annual Meeting
Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.
Neuroscience 2022
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall. Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.
AAO 2022
The mission of the American Academy of Ophthalmology is to protect sight and empower lives by serving as an advocate for patients and the public, leading ophthalmic education, and advancing the profession of ophthalmology.
ARVO 2023
The ARVO Annual Meeting is the premiere gathering for eye and vision scientists at all career stages, students, and those in affiliated fields to share the latest research findings and collaborate on innovative solutions. For 2023, the Meeting will be hosted April 23 – 27 in New Orleans, La.
Doheny Annual CME Conference
Please join us for a half-day conference that will feature presentations covering a range of ophthalmic topics presented by Doheny alumni, Doheny and Stein faculty, and Dr. Van Gelder in areas of clinical practice, research, and diagnostic advances for improved patient care.
Distinguished Lecture Series – Maya Koronyo-Hamaoui, PhD
Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer’s disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer’s pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.
Deborah A. Ferrington, PhD
Deborah A. Ferrington, PhD Chief Scientific OfficerDoheny Eye Institute PubMed Lab i CV Academic Degrees Bachelor of Science University of Pittsburgh, Pennsylvania Master of Education University of Pittsburgh, Pennsylvania Doctor of Philosophy Department of...Peng Shang, PhD
Peng Shang, PhD Research ScientistDoheny Eye Institute PubMed Lab i CV Academic Degrees Bachelor of Engineering Biological Engineering, Hunan University of Science and Technology Doctor of Philosophy Biomedical Engineering, Tongji University Postdoctoral...Distinguished Lecture Series – Maya Koronyo-Hamaoui, PhD
Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer’s disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer’s pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.
Distinguished Lecture Series – Alzheimer’s Disease Landscape in The Retina
Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer’s disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer’s pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.
Doheny and Stein Eye Institutes Alumni Reception at AAO
Join us for our annual alumni reception at the AAO annual meeting in Chicago on Sunday, October 2nd.
Meet Molly Ann Woods, CFRE, Doheny’s Chief Development Officer
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Molly Ann Woods, CFRE, is joining the organization as Chief Development Officer (CDO)
LHON Forum 2022
“Leber hereditary optic neuropathy (LHON) is a blinding mitochondrial disease that disproportionately affects young men. The diagnosis can be challenging with significant delays before a confirmed molecular diagnosis is reached. In this LHON Forum, we will discuss exciting developments in the field highlighting how a deeper understanding of the pathological mechanisms contributing to retinal ganglion cell loss is shaping the therapeutic landscape for this inherited optic nerve disorder.”
Judy Chen, MD
Judy Chen, MD Office Locations Academic Degrees Bachelor of Science University of California, Los Angeles Doctor of Medicine David Geffen School of Medicine at UCLA Residency Ophthalmology Illinois Eye and Ear Infirmary Fellowships Uveitis UCLA Stein Eye Institute... DLS – Maria Grant
LHON Forum 2022
Leber hereditary optic neuropathy (LHON) is a blinding mitochondrial disease that disproportionately affects young men. The diagnosis can be challenging with significant delays before a confirmed molecular diagnosis is reached. In this LHON Forum, we will discuss exciting developments in the field highlighting how a deeper understanding of the pathological mechanisms contributing to retinal ganglion cell loss is shaping the therapeutic landscape for this inherited optic nerve disorder.
Register for the LHON Forum 2022, November 28 at 20:00 hrs CET (11:00 am PST)
Register by contacting Gerard Bienfait at
A live broadcast from Doheny Eye Institute, Pasadena USA
Title: The current state of understanding and treatment for LHON
Block 1
Chair: Professor Patrick Yu Wai Man (Cambridge, UK)
Genetics: Professor Valerio Carelli (Bologna, Italy)
Mechanisms/pathways: Professor Alfredo A. Sadun (Los Angeles, USA)
Diagnose: Dr. Chiara La Morgia (Bologna, Italy)
Discussion
Block 2
Chair: Professor Patrick Yu Wai Man (Cambridge, UK)
LEROS: Professor Thomas Klopstock (Munich, Germany)
Gene therapy: Professor Nancy Newman (Atlanta, USA)
Window of opportunity/ chronic patients: Professor Marcela Votruba (Cardiff, UK)
Discussion
LHON
Stein and Doheny Eye Institutes, UCLA Medical Center
Season’s Greetings
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Molly Ann Woods, CFRE, is joining the organization as Chief Development Officer (CDO)
2022 Fall InSight Newsletter
Featured in this issue: New Campus Progresses, Connecting the Dots – Interdisciplinary Science Guides Vascular Research, Glaucoma Success–A Team Effort, Dr. Sun Seeks Disease Triggers
Research to Prevent Blindness Awards Doheny Researcher, Kaustabh Ghosh, PhD the Catalyst Award
Doheny-UCLA researcher, Yuhua Zhang, PhD, is the most recent recipient of the Catalyst Award from Research to Prevent Blindness
DLS
Sreekumar P Gangadharan, PhD
Sreekumar P Gangadharan, PhD Research ScientistDoheny Eye Institute PubMed Lab Academic Degrees Bachelor of Science University of Kerala, India Master of Science University of Kerala, India Doctor of Philosophy University of Kerala, India Postdoctoral Fellowships...Research to Prevent Blindness Awards Doheny-UCLA clinician-scientist, Victoria Tseng, MD, PhD Career Development Award
Doheny-UCLA clinician-scientist, Victoria Tseng, MD, PhD, has been awarded the Career Development Award from Research to Prevent Blindness
Creating a Diverse and Inclusive Online Experience at Doheny Eye Institute
To support everyone throughout our workforce and customer base, Doheny Eye Institute now provides enhanced accessibility support online to create a barrier-free user experience.
Annual Alumni Dinner Honoring Mark Borchert, MD
All friends, colleagues, family, and alumni are invited to celebrate this year’s honoree, Mark S. Borchert, MD, of CHLA. Each year the Doheny Professional Association honors a member as the “Distinguished Alumnus” for achievement and commitment to the advancement of ophthalmic research, education, or patient care. The annual dinner is immediately following the conference. RSVPs can be made at doheny.org/alumni23.
Annual Doheny-UCLA Stein Reception at ARVO
We hope you will join us on Monday, April 24, 2023 to reconnect with friends and colleagues at our annual reception held during the ARVO meeting. This year ARVO will take place in New Orleans, LA, from Sunday, April 23 – Wed, April 26
Doheny-UCLA Breakfast Forum at ARVO
This year’s theme is Accelerating Discovery of Disease Mechanism: High-Resolution Imaging Links Structure to Function. The seminar will feature internationally recognized leaders in developing and using advanced retinal imaging. They will cover the latest developments in adaptive optics imaging, optical coherence tomography, and fluorescence lifetime imaging ophthalmoscopy.
Learn about the latest eye drops recall from Benjamin Bert, MD, FACS
Dr. Ben Bert discusses two more recalls of eye drops with KNX In Depth’s Charles Feldman and Rob Archer. Learn more about potential contamination risks that could lead to serious injury or vision problems.
Doheny Eye Institute CEO Marissa Goldberg and Chief Scientific Officer Deborah A. Ferrington, PhD, Recognized for Leadership by the Los Angeles Business Journal
The momentum is building as Doheny Eye Institute continues to see a growing spotlight for its contributions to ocular research, exemplified by recent accolades for CEO Marissa Goldberg and Chief Scientific Officer Deborah Ferrington, PhD, from the Los Angeles Business Journal (LABJ).
Giulia Corradetti, MD
Giulia Corradetti, MD Research ScientistDoheny Eye Institute PubMed Lab Academic Degrees Doctor of Medicine University of Bologna, Italy Residency Ophthalmology Scientific Institute San Raffaele Milan,Italy Fellowships Pediatric Ophthalmology & Strabismus...Dr. SriniVas R. Sadda named 2023-2024 ARVO President-elect
27 June 2023 Click Here to view Dr. Sadda’s Profile Page – FOR IMMEDIATE RELEASE – Dr. SriniVas R. Sadda named 2023-2024 ARVO President-elect Los Angeles, CA, June 27, 2023 – SriniVas R. Sadda, MD, was recently named president-elect of... Doheny Eye Institute
CME – 5th Annual Doheny-UCLA International Glaucoma Symposium
Register for the 5th Annual Doheny-UCLA International Glaucoma Symposium to be held at Doheny Eye Institute on Saturday, September 30, 2023. This will be a half-day conference featuring dynamic presentations covering imaging pearls, medical & surgical management...Doheny and Stein Eye Institutes Alumni Reception at AAO
Join us for our annual Alumni Reception at the 2023 American Academy of Ophthalmology (AAO) annual meeting as part of the UCLA Department of Ophthalmology. Sunday, November 5, 2023 5:30 p.m. – 9:30 p.m. St. Regis Hotel, the Conservatory Room 125 3rd St. San Francisco,...LHON Forum 2023
Leber hereditary optic neuropathy (LHON) is a blinding mitochondrial disease that disproportionately affects young men. The diagnosis can be challenging with significant delays before a confirmed molecular diagnosis is reached. In this LHON Forum, we will discuss exciting developments in the field highlighting how a deeper understanding of the pathological mechanisms contributing to retinal ganglion cell loss is shaping the therapeutic landscape for this inherited optic nerve disorder.
Dr. Alfredo Sadun presented the keynote lecture “The optic nerve in mitochondrial neurological conditions”, at the EUROMIT 2023 meeting in Bologna, Italy; Upcoming: Dr. Sadun will participate in a webinar on Leber Hereditary Optic Neuropathy (LHON) presented by the Optic Nerve Network on July 21, 2023 at 10:00 a.m. He will be discussing mitochondrial gene defects and anatomical and metabolic considerations.
To register for the webinar: https://www.webinaronlhon.com/webinar2023/#Registration_Information
2023 InSight Newsletter
2023 Insight Newsletter – Learn the Power of Collaborative Science
Ophthalmology Times: Cellular evidence of retinal ganglion cell transfection after LHON treatment
Video Transcript Editor’s note – This transcript has been edited for clarity. David Hutton: I’m David Hutton of Ophthalmology Times. At its annual meeting earlier this year, the Association for Research in Vision and Ophthalmology, named Dr. SriniVas...Hot tips for protecting your Eyes: UV Safety Tips
Hot tips for protecting your eyes this summer: UV Safety Tips AUGUST With the sun shining brightly, Doheny Eye Institute is here to remind you of the importance of safeguarding your eyes from harmful ultraviolet (UV) rays. UV exposure can lead to serious eye...PAA EYE on Alumni – Summer News 2023
Staying Connected and Focused on the Future; Greetings and Welcome to the New Quarterly PAA Enewsletter
Celebrate Children’s Eye and Safety Month!
Children’s Eye Health and Safety Month AUGUST August is Children’s Eye Health and Safety Month and at Doheny Eye Institute, we believe that healthy eyes pave the way for endless possibilities and vibrant futures. Let’s dive into our top tips to...DEI Recognized by Pasadena Magazine as Top Doctors
Pasadena Magazine recognized Dr. Sadda and Dr. Sadun as Top Doctors in their September/October 2023 issue. View the online flipbook from the publisher using the link below. Read more... 2023 International Glaucoma Symposium: “Glaucoma Surgeries: MIGS vs. Traditional”
Steven Barnes, PhD, receives a R01 grant for groundbreaking research
28 August 2023 Click Here to view Dr. Steven Barnes’ Profile Page – FOR IMMEDIATE RELEASE – Steven Barnes, PhD, Selected to Receive Five-Year NIH Research Grant Pasadena, CA, August 28, 2023 – Steven Barnes, PhD, Principal Investigator...InSight at a Glance | August 2023
August 2023 Annual Doheny Planned Giving Luncheon On June 6, several of our esteemed donors and guests gathered at Doheny Eye Institute for a special luncheon. This annual event offered our guests the opportunity to learn more about Doheny’s...Los Angeles Business Journal; 2023 Health Care Leadership Symposium & Awards Finalists
Our Chief Scientific Officer, Deborah Ferrington was recently recognized by the Los Angeles Business Journal. In response to the need for quality mental health care for older adults, Ari D. Kalechstein, Ph.D. and his company, Executive Mental Health (EMH) work to...Trends may shift AMD treatment paradigm With Modern Retina
Modern Retina recently covered our conversation with Ophthalmology Times. There once were no treatment options for age-related macular degeneration (AMD), the leading cause of irreversible blindness in the elderly, but there now are multiple therapies available for...PNAS: Coenzyme Q10 trapping in mitochondrial complex I underlies Leber’s hereditary optic neuropathy
AUTHORS: Jack T. Fuller, III; Steven Barnes; Lorenzo A. Sadun; Pujan Ajmera; Anastassia N. Alexandrova; Alfredo A. Sadun In the genetic disease Leber’s hereditary optic neuropathy, inheritance of a specific, single mitochondrial DNA mutation can produce the sudden...InSight at a Glance | September 2023
September 2023 Doheny Closes out 75th Anniversary with Eyes on the Future Last month marked the end of our 75th year, closing out a remarkable time for Doheny Eye Institute – from our founding by Carrie Estelle Doheny in 1947 after she lost the sight in...Nariman Nassiri, MD
Nariman Nassiri, MD i Pub MD Office Locations Academic Degrees Master of Public Health Johns Hopkins Bloomberg School of Public Health Doctor of Medicine Tehran University of Medical Sciences Residency Ophthalmology Kresge Eye InstituteWayne State UniversityDetroit,...PAA EYE on Alumni – Fall News 2023
It is hard to believe that the end of another calendar year is fast approaching, but there is much to look forward to as we embrace the final months of 2023 and anticipate the arrival of 2024.
InSight at a Glance | October 2023
October 2023 Dr. Barnes and Dr. Ferrington Jeff Golberg, Doheny CEO Marissa Goldberg, and Jeremy Poincenot and his mother, Lissa Expressing our Gratitude at the Annual Donor Appreciation Event It...Fall 2023 InSight Newsletter
Fall 2023 Insight Newsletter – From Outer Space to Inner Vision
FDA warns consumers not to purchase or use certain eye drops from several major brands due to risk of eye infection
31 October 2023 News: FDA warns consumers not to purchase or use certain eye drops from several major brands due to risk of eye infection. FDA is updating the list of over-the-counter eye drop products consumers should not purchase or use to include Equate Hydration...Doheny Eye Institute Research Breakthrough: Stiffening of retinal blood vessels threatens vision in diabetes
21 November 2023 Click Here to view Dr. Ghosh’s Profile Doheny Eye Institute Research Breakthrough: Stiffening of retinal blood vessels threatens vision in diabetes Using atomic force microscopy, researchers at Doheny Eye Institute, an affiliate of UCLA,...InSight at a Glance | November 2023
November 2023 Doheny-UCLA Affiliation Marks 10th Anniversary This December we proudly celebrate the 10th anniversary of the Doheny Eye Institute and UCLA Stein Eye Institute affiliation, a fruitful partnership that continues to elevate groundbreaking...Doheny Distinguished Lecture Series December 2023 featuring Valerio Carelli and Chiara La Morgia
Doheny Distinguished Lecture Series December 2023 featuring Valerio Carelli and Chiara La Morgia
Doheny Distinguished Lecture Series January 2024 featuring Maureen Neitz, PhD
Doheny Distinguished Lecture Series January 2024 – “Genetic discoveries that led to the contrast theory of myopia and the development of Diffusion Optic Technology spectacles” featuring Maureen Neitz, PhD, Ray and Grace Hill Endowed Chair in Ophthalmology and Director of Graduate Program in Neuroscience, University of Washington
Doheny Distinguished Lecture Series February 2024 — Lois Smith, MD, PhD
Friday, February 16, 2024 — Can we prevent retinopathy by improving mitochondrial metabolism? Our 2023-24 Doheny Distinguished Lecture Series February lecture will be delivered by Lois Smith, MD, PhD, Professor of Ophthalmology at Boston Children’s Hospital and Harvard Medical
Doheny Distinguished Lecture Series April 2024 — Christine Curcio, PhD
Doheny Distinguished Lecture Series April 2024 — Christine Curcio, PhD
Distinguished Lecture Series 23-24- Valerio Carelli
Dr. SriniVas R. Sadda Recognized with Retina Research Foundation Merit Award for Groundbreaking Research on Retinal Disease
23 October 2023 Click Here to view Dr. Sadda’s Profile Dr. SriniVas R. Sadda Recognized with Retina Research Foundation Merit Award for Groundbreaking Research on Retinal Disease October 14, 2023 — SriniVas R. Sadda, MD, director of the Doheny Eye...Ophthalmology Times: Cellular evidence of retinal ganglion cell transfection after LHON treatment
Alfredo A. Sadun, MD, PhD, and colleagues conducted an international post-mortem study of human eyes treated with adeno-associated virus (AAV2)-based gene therapy for Leber hereditary optic neuropathy (LHON). The results were reported at the American Academy of...CME – Event
2nd Annual Doheny-UCLA International Retina Symposium; January 27, 2024, 7 AM – 4:30 p.m. About the Course:
This course is tailored to update practicing ophthalmologists and related health care specialists on recent advances and controversies in the management of a variety of posterior segment disorders. The desired result is to gain and develop an evidence based approach to the management of patients with retinal disease.
CME – 2nd Annual Doheny-UCLA International Retina Symposium
REGISTER NOW Doheny Eye Institute acknowledges with gratitude the following organizations for their participation: Educational Grantors Genentech, a member of the Roche Group • Iveric Bio Regeneron • REGENXBIO Inc. • Zeiss ExhibitorsAlcon • ...Physicians Weekly: Aqueous Shunts with Extraocular Reservoir for Open-Angle Adult Glaucoma: A Report by the American Academy of Ophthalmology
CONTRIBUTORS: Vikas Chopra, Hana L. Takusagawa, Jullia A. Rosdahl, Arthur J. Sit, Grace M Richter, Yvonne Ou, Stephen J. Kim, Darrell WuDunn To evaluate the recently published literature on the efficacy and safety of the use of aqueous shunts with extraocular...Medika Life: Revolutionizing Retinal Imaging: The Role of Artificial Intelligence
By: Dr. SriniVas R. Sadda AI is poised to be instrumental in the decision-making process for physicians, but ultimately, it cannot replace the human element. Retinal imaging is critical in the field of ophthalmology and provides a trove of information that enables...Distinguished Lecture Series – January 2024
Doheny CME Annual Conference
Annual CME Conference and Society of Scholars Ceremony This full-day conference will feature presentations covering a range of ophthalmic topics in neuro-ophthalmology, anterior segment, and uveitis. Material will be presented by Doheny-UCLA faculty and Doheny alumni...Doheny Distinguished Alumni Dinner
The Doheny Professional Alumni AssociationInvites You to Attend the 2024 Distinguished Alumni Dinner Honoring Lawrence Chong, MD Location:The Valley Hunt Club520 S. Orange Grove BlvdPasadena, CA 91105 Tickets $125 eachDress Code: Sports coats required Kindly...PAA EYE on Alumni – Winter News 2024
Happy New Year! With the holidays now a few weeks behind us, Doheny Eye Institute is full steam ahead – both with continuing critical research in the laboratories and also planning our many highly-anticipated annual meetings, symposiums, alumni gatherings and more.
Doheny Eye Institute Research Breakthrough
29 January 2024 Click Here to view Dr. Steven Barnes’ Profile Page Click Here to view Dr. Alfredo A. Sadun’s Profile Page – FOR IMMEDIATE RELEASE – Doheny Eye Institute Research Breakthrough: An Inherited Mutation Blinds Young Adult Males By...InSight at a Glance | January 2024
January 2024 Carrie Estelle Doheny Foundation Generously Donates $1.5M to Doheny Eye Institute Doheny Eye Institute is thrilled to announce that the Carrie Estelle Doheny Foundation has generously donated $1.5M to support our vision research over the...Distinguished Lecture Series – Februrary 2024
Doctors Sadda and Sadun Named as Top Doctors
6 February 2024 Click Here to view Dr. Sadda’s Profile Page Click Here to view Dr. Alfredo A. Sadun’s Profile Page SriniVas R. Sadda, MD, and Alfredo A. Sadun, MD, PhD, Named to Los Angeles Business Journal’s Top Doctors 2024 List Each year, the Los...Cataract and Cataract Surgery — Benjamin Bert, MD, FACS
Cataracts affect more than 24.4 million Americans aged 40 and older. By age 75, approximately half of Americans will have cataracts. Tune in for a special presentation from Benjamin Bert, MD, FACS of Doheny Eye Center UCLA. Dr. Bert will share the latest information regarding cataract and cataract surgery. This virtual presentation is hosted by the Braille Institute.
Cataract and Cataract Surgery — February 20
IOVS: Potential Structural Biomarkers in 3D Images Validated by the First Functional Biomarker for Early Age-Related Macular Degeneration – ALSTAR2 Baseline
AUTHORS: Sohaib Fasih-Ahmad; Ziyuan Wang; Zubin Mishra; Charles Vatanatham; Mark E. Clark; Thomas A. Swain; Christine A. Curcio; Cynthia Owsley; SriniVas R. Sadda; Zhihong Jewel Hu Age-related macular degeneration (AMD) is a leading cause of irreversible central...CME 2024 – Event
This full-day conference will feature presentations covering a range of ophthalmic topics in neuro-ophthalmology, anterior segment and uveitis. Material will be presented by Doheny-UCLA faculty and Doheny alumni in areas of clinical practice, research, and diagnostic advances for improved patient care.
Doheny Alumnus Honored by President Biden
22 February 2024 David Huang, MD, PhD Doheny Alumnus Honored by President Biden We are proud to share that David Huang, MD, PhD, who received ophthalmology residency training at Doheny Eye Institute/University of Southern California (1994–97) and began his...InSight at a Glance | February 2024
February 2024 SriniVas R. Sadda, MD, and Alfredo A. Sadun, MD, PhD, Named to Los Angeles Business Journal’s Top Doctors 2024 List Each year, the Los Angeles Business Journal Top Doctors in Los Angeles list shines a spotlight on the local doctors who help...Healio Q&A: Look for signs of AMD even in those without family history
AUTHORS: Deborah Ferrington, PhD, Sara Kellner, Kate YoungFact checked by: Heather Biele Age-related macular degeneration can occur even in patients without a family history, so clinicians must be aware of early warning signs of the disease, according to Deborah...Distinguished Lecture Series – April 2024
2024 ARVO Annual Alumni Reception
2024 ARVO Annual Alumni Reception Join us for a night of reconnecting, networking, and celebrating our shared passion for eye health. The event will take place in person at the Sheraton Grand Seattle, so mark your calendars and get ready for a memorable evening....Doheny-UCLA Breakfast Forum at ARVO 2024
Fresh Perspectives on Retinopathy Retinopathy remains the leading cause of vision loss in the global working population. Regardless of whether it is triggered by ischemia or diabetes, the late vision-threatening stage of retinopathy is marked by VEGF-mediated...2024 ARVO Annual Alumni Reception
Doheny-UCLA Breakfast Forum at ARVO
Ophthalmology Times: Afredo A. Sadun, MD, PhD, discusses research targeting LHON
By: David Hutton Scientists at the Doheny Eye Institute, in collaboration with UCLA chemists, demonstrate how a single gene mutation in an enzyme complex known to produce the energy required by cells causes a sudden, blinding disease. In a recent conversation with...Ophthalmology Times: Afredo A. Sadun, MD, PhD
Medika Life: Research Drives AMD Treatments Toward Targeted Therapies
By: Deborah Ferrington PhD Age-related macular degeneration (AMD) is the leading cause of blindness for those 55 years and older. As the population ages — not only in the U.S. but worldwide — there is a greater sense of urgency to discover therapies that can...Medika Life: Deborah Ferrington, PhD
InSight at a Glance | March 2024
March 2024 Doheny Welcomes New Planned Giving Associate Director Doheny Eye Institute is pleased to introduce our new Associate Director of Planned Giving Heidi Simpson-Sandoval. Ms. Simpson-Sandoval officially joined Doheny in December as part of the...Vision Monday: Doheny Eye Institute Starts Construction of New Eye Center
By: Vision Monday Staff PASADENA, Calif. — Doheny Eye Institute has announced that construction is underway for the new Doheny Eye Center UCLA location in Pasadena, California. The center will be housed on the first floor of the seven-acre Doheny Eye Institute campus,...UCLA Department of Ophthalmology Annual Seminar
UCLA Department of Ophthalmology Annual SeminarJune 7, 2024UCLA Stein Eye Institute • RPB Auditorium MEETING HIGHLIGHTS 54th Doheny Memorial Lecturer Joseph F. Rizzo III, MDSimmons Lessell Professor of OphthalmologyMassachusetts Eye & Ear Infirmary 54th...PAA EYE on Alumni – Spring News 2024
Greetings, and happy Spring! Doheny Eye Institute is in the midst of one of our busiest seasons of the year. This is also a period in which we enjoy several opportunities to reconnect in person with our Doheny Professional Alumni Association members.